Why Brown & Brown (BRO) is Back on Investors’ Radar

Brown & Brown (BRO) has drawn fresh attention after recent trading left the stock about 25% lower year to date, with the share price at US$58.05 and a market value near US$19.2b.

The 1-day share price return of 2.63% sits against a 30-day share price return of 12.54% and a year to date share price return of 25.21%. The 1-year total shareholder return of 47.57% contrasts with a 3-year total shareholder return of 9.97% and a 5-year total shareholder return of 14.94%, pointing to fading momentum after a stronger long run.

If Brown & Brown’s recent moves have you reassessing your watchlist, it could be a good moment to widen the lens and check out 18 top founder-led companies

With Brown & Brown trading at US$58.05, sitting at a discount to some intrinsic and analyst estimates despite ongoing revenue and net income growth, you have to ask: is this a genuine entry point, or is the market already pricing in future growth?

Most Popular Narrative: 21.3% Undervalued

With Brown & Brown closing at $58.05 against a narrative fair value of $73.80, the current price sits well below what this widely followed view suggests.

Strong cash flow from operations, combined with a strategic focus on leveraging a diversified portfolio across geographies and lines of business, positions the company to navigate economic uncertainties and potentially increase future earnings stability and growth.

Curious what kind of revenue trajectory, margin profile, and future earnings multiple are baked into that fair value label? The underlying assumptions are anything but conservative.

Result: Fair Value of $73.80 (UNDERVALUED)

However, this hinges on expectations that could be tested by weaker revenue growth or by margin pressure from higher pharmacy costs and shifts in CAT property pricing.

Another Way to Look at Valuation

That narrative fair value of $73.80 leans heavily on forecasts, but the current P/E of 17.3x tells a different story. It sits above the US Insurance industry at 11.4x and above a fair ratio of 12.7x, which points to valuation risk if sentiment cools.

Before you put too much weight on any single number, it is worth seeing how this P/E gap stacks up against peers and what the market could move toward over time, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With sentiment pulled in different directions by valuation, growth expectations, and recent returns, it helps to move quickly and test the numbers yourself. Start with the 4 key rewards and 2 important warning signs

Looking for more investment ideas?

If you stop with just one stock, you could miss other opportunities that better fit your goals. Take a few minutes to scan the market with focused lists built from the Simply Wall St Screener.

• Target potential mispricings by reviewing 51 high quality undervalued stocks that combine quality fundamentals with room for the market to reassess.
• Strengthen your income stream by checking out 12 dividend fortresses that aim to pair yield with resilience.
• Prioritise resilience first by scanning 71 resilient stocks with low risk scores that may suit investors who want a smoother ride.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.